September 17, 2025 - 01:59

Lulu Gribbin, a remarkable individual who lost a hand and leg due to a shark attack, captivated attendees at an assistive technology conference in Birmingham. Sharing her personal journey, Gribbin highlighted the challenges she faced and the resilience she developed in the aftermath of her traumatic experience.
During her speech, she emphasized the importance of assistive technology in enhancing the quality of life for individuals with disabilities. Gribbin passionately advocated for greater accessibility and innovation in technology, demonstrating how these tools can empower people to lead more independent and fulfilling lives.
Her story resonated deeply with the audience, many of whom were inspired by her strength and determination. Gribbin's advocacy work aims to raise awareness about the needs of those with disabilities and to promote solutions that can help them navigate everyday challenges. The conference served as a platform for her to connect with others and share her vision for a more inclusive future.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...